RETRACTABLE TECHNOLOGIES Business Summary

Retractable Technologies Inc (RVP) operates as a specialized medical device manufacturer generating revenue primarily through the high-volume sale of safety-engineered syringes and needle devices. The company’s business model is centered on the commercialization of its proprietary friction-ring and automated needle retraction (ANR) technologies, which are designed to eliminate needlestick injuries and prevent product reuse. Primary business segments include safety syringes (VanishPoint and EasyPoint), blood collection tube holders, and IV safety catheters, with approximately 87% of revenue derived from domestic U.S. sales as of late 2025. RVP occupies a niche position as a safety-focused innovator, competing directly against diversified industry giants such as Becton Dickinson (BD), Meihua International Medical Technologies, and Rockwell Medical. While it maintains a significant share of the retractable injection market, the company currently operates as a micro-cap player focused on mitigating high import tariffs by shifting production to its domestic Texas-based manufacturing facilities. The company was founded in 1994 by Thomas J. Shaw, who continues to lead the organization as Chairman, President, and Chief Executive Officer. Shaw, an industrial designer by trade, holds a controlling interest of approximately 55% of the company’s common stock and is the primary architect of its patented safety technologies. The executive leadership team includes John W. Fort III, who serves as Vice President, Chief Financial Officer, and Treasurer, and Michele M. Larios, the Vice President and General Counsel. Other key officers include Kathryn M. Duesman (VP of Clinical Affairs) and Kevin McGlinchey (VP of Sales). The company’s Board of Directors features a mix of long-tenured insiders and independent members, including Marco Laterza, Amy Mack, and Walter Bigby Jr. Despite its small-cap status, RVP maintains institutional backing from major investment firms such as The Vanguard Group and BlackRock, Inc.